APO Research
Talk to an analyst

APO RESEARCH · REPORT

Targeted RNA Sequencing

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.

In the report, we only collect information about the companies who can provide targeted RNA sequencing service.

Selected research

Market Analysis & Forecast

Global Targeted RNA Sequencing Market Analysis and Forecast 2026-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchTargeted RNA Sequencing Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Targeted RNA Sequencing Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Targeted RNA Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Targeted RNA Sequencing Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Targeted RNA Sequencing Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.

In the report, we only collect information about the companies who can provide targeted RNA sequencing service.

Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.

Read the full market overview

North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.

Report Includes

This report presents an overview of global market for Targeted RNA Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Targeted RNA Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Targeted RNA Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Targeted RNA Sequencing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Targeted RNA Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Targeted RNA Sequencing revenue, projected growth trends, production technology, application and end-user industry.

Targeted RNA Sequencing Segment by Company

Thermo Fisher

Illumina

Roche Holdings

BGI

Eurofins

LabCorp

Berry Genomics

Macrogen

GENEWIZ

Targeted RNA Sequencing Segment by Type

Exome Sequencing

Enrichment Sequencing

Amplicon Sequencing

Targeted RNA Sequencing Segment by Application

Research Institutes

Hospitals & Clinics

Biotechnology Company

Diagnostic Lab

Targeted RNA Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted RNA Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Targeted RNA Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted RNA Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Targeted RNA Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Targeted RNA Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted RNA Sequencing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Targeted RNA Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Exome Sequencing Major Player Table 3. Enrichment Sequencing Major Player Table 4. Amplicon Sequencing Major Player Table 5. Global Targeted RNA Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Research Institutes Major Player Table 7. Hospitals & Clinics Major Player Table 8. Biotechnology Company Major Player Table 9. Diagnostic Lab Major Player Table 10. Targeted RNA Sequencing Industry Trends Table 11. Targeted RNA Sequencing Industry Drivers Table 12. Targeted RNA Sequencing Industry Opportunities and Challenges Table 13. Targeted RNA Sequencing Industry Restraints Table 14. Global Targeted RNA Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Targeted RNA Sequencing Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Targeted RNA Sequencing Market Share by Region (2021-2026) Table 17. Global Targeted RNA Sequencing Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Targeted RNA Sequencing Market Share by Region (2027-2032) Table 19. Global Targeted RNA Sequencing Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Targeted RNA Sequencing Revenue Market Share by Players (2021-2026) Table 21. Global Targeted RNA Sequencing Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Targeted RNA Sequencing Key Players Headquarters & Area Served Table 23. Global Targeted RNA Sequencing Players, Product Type & Application Table 24. Global Targeted RNA Sequencing Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Targeted RNA Sequencing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Targeted RNA Sequencing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Targeted RNA Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Targeted RNA Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Targeted RNA Sequencing Revenue Market Share by Type (2021-2026) Table 31. Global Targeted RNA Sequencing Revenue Market Share by Type (2027-2032) Table 32. Global Targeted RNA Sequencing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Targeted RNA Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Targeted RNA Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Targeted RNA Sequencing Revenue Market Share by Application (2021-2026) Table 36. Global Targeted RNA Sequencing Revenue Market Share by Application (2027-2032) Table 37. Thermo Fisher Company Information Table 38. Thermo Fisher Business Overview Table 39. Thermo Fisher Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Thermo Fisher Targeted RNA Sequencing Product Portfolio Table 41. Thermo Fisher Recent Development Table 42. Illumina Company Information Table 43. Illumina Business Overview Table 44. Illumina Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Illumina Targeted RNA Sequencing Product Portfolio Table 46. Illumina Recent Development Table 47. Roche Holdings Company Information Table 48. Roche Holdings Business Overview Table 49. Roche Holdings Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Roche Holdings Targeted RNA Sequencing Product Portfolio Table 51. Roche Holdings Recent Development Table 52. BGI Company Information Table 53. BGI Business Overview Table 54. BGI Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. BGI Targeted RNA Sequencing Product Portfolio Table 56. BGI Recent Development Table 57. Eurofins Company Information Table 58. Eurofins Business Overview Table 59. Eurofins Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Eurofins Targeted RNA Sequencing Product Portfolio Table 61. Eurofins Recent Development Table 62. LabCorp Company Information Table 63. LabCorp Business Overview Table 64. LabCorp Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. LabCorp Targeted RNA Sequencing Product Portfolio Table 66. LabCorp Recent Development Table 67. Berry Genomics Company Information Table 68. Berry Genomics Business Overview Table 69. Berry Genomics Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Berry Genomics Targeted RNA Sequencing Product Portfolio Table 71. Berry Genomics Recent Development Table 72. Macrogen Company Information Table 73. Macrogen Business Overview Table 74. Macrogen Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Macrogen Targeted RNA Sequencing Product Portfolio Table 76. Macrogen Recent Development Table 77. GENEWIZ Company Information Table 78. GENEWIZ Business Overview Table 79. GENEWIZ Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. GENEWIZ Targeted RNA Sequencing Product Portfolio Table 81. GENEWIZ Recent Development Table 82. North America Targeted RNA Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Targeted RNA Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Targeted RNA Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Targeted RNA Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Targeted RNA Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Targeted RNA Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 88. North America Targeted RNA Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 89. Europe Targeted RNA Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Targeted RNA Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Targeted RNA Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe Targeted RNA Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe Targeted RNA Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Europe Targeted RNA Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 95. Europe Targeted RNA Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 96. China Targeted RNA Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 97. China Targeted RNA Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 98. China Targeted RNA Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 99. China Targeted RNA Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 100. Asia Targeted RNA Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 101. Asia Targeted RNA Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 102. Asia Targeted RNA Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 103. Asia Targeted RNA Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Targeted RNA Sequencing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Asia Targeted RNA Sequencing Revenue by Region (US$ Million) & (2021-2026) Table 106. Asia Targeted RNA Sequencing Revenue by Region (US$ Million) & (2027-2032) Table 107. SAMEA Targeted RNA Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 108. SAMEA Targeted RNA Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 109. SAMEA Targeted RNA Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 110. SAMEA Targeted RNA Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 111. SAMEA Targeted RNA Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. SAMEA Targeted RNA Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 113. SAMEA Targeted RNA Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Targeted RNA Sequencing Image Figure 2. Global Targeted RNA Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Targeted RNA Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Exome Sequencing Image Figure 5. Enrichment Sequencing Image Figure 6. Amplicon Sequencing Image Figure 7. Global Targeted RNA Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Targeted RNA Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Research Institutes Image Figure 10. Hospitals & Clinics Image Figure 11. Biotechnology Company Image Figure 12. Diagnostic Lab Image Figure 13. Global Targeted RNA Sequencing Market Size (US$ Million) & (2021-2032) Figure 14. Global Targeted RNA Sequencing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Targeted RNA Sequencing Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Targeted RNA Sequencing Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Targeted RNA Sequencing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Targeted RNA Sequencing Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Targeted RNA Sequencing Revenue Market Share by Type (2021-2032) Figure 21. Global Targeted RNA Sequencing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Targeted RNA Sequencing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Targeted RNA Sequencing Revenue Market Share by Application (2021-2032) Figure 24. North America Targeted RNA Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Targeted RNA Sequencing Revenue Share by Type (2021-2032) Figure 26. North America Targeted RNA Sequencing Revenue Share by Application (2021-2032) Figure 27. North America Targeted RNA Sequencing Revenue Share by Country (2021-2032) Figure 28. United States Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Targeted RNA Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Targeted RNA Sequencing Revenue Share by Type (2021-2032) Figure 33. Europe Targeted RNA Sequencing Revenue Share by Application (2021-2032) Figure 34. Europe Targeted RNA Sequencing Revenue Share by Country (2021-2032) Figure 35. Germany Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Targeted RNA Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Targeted RNA Sequencing Revenue Share by Type (2021-2032) Figure 45. China Targeted RNA Sequencing Revenue Share by Application (2021-2032) Figure 46. Asia Targeted RNA Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Targeted RNA Sequencing Revenue Share by Type (2021-2032) Figure 48. Asia Targeted RNA Sequencing Revenue Share by Application (2021-2032) Figure 49. Asia Targeted RNA Sequencing Revenue Share by Region (2021-2032) Figure 50. Japan Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Targeted RNA Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Targeted RNA Sequencing Revenue Share by Type (2021-2032) Figure 58. SAMEA Targeted RNA Sequencing Revenue Share by Application (2021-2032) Figure 59. SAMEA Targeted RNA Sequencing Revenue Share by Country (2021-2032) Figure 60. Brazil Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Targeted RNA Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Exome Sequencing
  • Enrichment Sequencing
  • Amplicon Sequencing
Applications
  • Research Institutes
  • Hospitals & Clinics
  • Biotechnology Company
  • Diagnostic Lab
Companies covered
  • Thermo Fisher
  • Illumina
  • Roche Holdings
  • BGI
  • Eurofins
  • LabCorp
  • Berry Genomics
  • Macrogen
  • GENEWIZ

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Targeted RNA Sequencing Market by Type
  3. 1.2.1 Global Targeted RNA Sequencing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Exome Sequencing
  5. 1.2.3 Enrichment Sequencing
  6. 1.2.4 Amplicon Sequencing
  7. 1.3 Targeted RNA Sequencing Market by Application
  8. 1.3.1 Global Targeted RNA Sequencing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Research Institutes
  10. 1.3.3 Hospitals & Clinics
  11. 1.3.4 Biotechnology Company
  12. 1.3.5 Diagnostic Lab
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Targeted RNA Sequencing Market Dynamics
  1. 2.1 Targeted RNA Sequencing Industry Trends
  2. 2.2 Targeted RNA Sequencing Industry Drivers
  3. 2.3 Targeted RNA Sequencing Industry Opportunities and Challenges
  4. 2.4 Targeted RNA Sequencing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Targeted RNA Sequencing Market Perspective (2021-2032)
  2. 3.2 Global Targeted RNA Sequencing Growth Trends by Region
  3. 3.2.1 Global Targeted RNA Sequencing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Targeted RNA Sequencing Market Size by Region (2021-2026)
  5. 3.2.3 Global Targeted RNA Sequencing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Targeted RNA Sequencing Revenue by Players
  2. 4.1.1 Global Targeted RNA Sequencing Revenue by Players (2021-2026)
  3. 4.1.2 Global Targeted RNA Sequencing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Targeted RNA Sequencing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Targeted RNA Sequencing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Targeted RNA Sequencing Key Players Headquarters & Area Served
  7. 4.4 Global Targeted RNA Sequencing Players, Product Type & Application
  8. 4.5 Global Targeted RNA Sequencing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Targeted RNA Sequencing Market CR5 and HHI
  11. 4.6.3 2025 Targeted RNA Sequencing Tier 1, Tier 2, and Tier 3
5 Targeted RNA Sequencing Market Size by Type
  1. 5.1 Global Targeted RNA Sequencing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Targeted RNA Sequencing Revenue by Type (2021-2032)
  3. 5.3 Global Targeted RNA Sequencing Revenue Market Share by Type (2021-2032)
6 Targeted RNA Sequencing Market Size by Application
  1. 6.1 Global Targeted RNA Sequencing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Targeted RNA Sequencing Revenue by Application (2021-2032)
  3. 6.3 Global Targeted RNA Sequencing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher
  2. 7.1.1 Thermo Fisher Company Information
  3. 7.1.2 Thermo Fisher Business Overview
  4. 7.1.3 Thermo Fisher Targeted RNA Sequencing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Targeted RNA Sequencing Product Portfolio
  6. 7.1.5 Thermo Fisher Recent Developments
  7. 7.2 Illumina
  8. 7.2.1 Illumina Company Information
  9. 7.2.2 Illumina Business Overview
  10. 7.2.3 Illumina Targeted RNA Sequencing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Illumina Targeted RNA Sequencing Product Portfolio
  12. 7.2.5 Illumina Recent Developments
  13. 7.3 Roche Holdings
  14. 7.3.1 Roche Holdings Company Information
  15. 7.3.2 Roche Holdings Business Overview
  16. 7.3.3 Roche Holdings Targeted RNA Sequencing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Roche Holdings Targeted RNA Sequencing Product Portfolio
  18. 7.3.5 Roche Holdings Recent Developments
  19. 7.4 BGI
  20. 7.4.1 BGI Company Information
  21. 7.4.2 BGI Business Overview
  22. 7.4.3 BGI Targeted RNA Sequencing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BGI Targeted RNA Sequencing Product Portfolio
  24. 7.4.5 BGI Recent Developments
  25. 7.5 Eurofins
  26. 7.5.1 Eurofins Company Information
  27. 7.5.2 Eurofins Business Overview
  28. 7.5.3 Eurofins Targeted RNA Sequencing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eurofins Targeted RNA Sequencing Product Portfolio
  30. 7.5.5 Eurofins Recent Developments
  31. 7.6 LabCorp
  32. 7.6.1 LabCorp Company Information
  33. 7.6.2 LabCorp Business Overview
  34. 7.6.3 LabCorp Targeted RNA Sequencing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 LabCorp Targeted RNA Sequencing Product Portfolio
  36. 7.6.5 LabCorp Recent Developments
  37. 7.7 Berry Genomics
  38. 7.7.1 Berry Genomics Company Information
  39. 7.7.2 Berry Genomics Business Overview
  40. 7.7.3 Berry Genomics Targeted RNA Sequencing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Berry Genomics Targeted RNA Sequencing Product Portfolio
  42. 7.7.5 Berry Genomics Recent Developments
  43. 7.8 Macrogen
  44. 7.8.1 Macrogen Company Information
  45. 7.8.2 Macrogen Business Overview
  46. 7.8.3 Macrogen Targeted RNA Sequencing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Macrogen Targeted RNA Sequencing Product Portfolio
  48. 7.8.5 Macrogen Recent Developments
  49. 7.9 GENEWIZ
  50. 7.9.1 GENEWIZ Company Information
  51. 7.9.2 GENEWIZ Business Overview
  52. 7.9.3 GENEWIZ Targeted RNA Sequencing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 GENEWIZ Targeted RNA Sequencing Product Portfolio
  54. 7.9.5 GENEWIZ Recent Developments
8 North America
  1. 8.1 North America Targeted RNA Sequencing Revenue (2021-2032)
  2. 8.2 North America Targeted RNA Sequencing Revenue by Type (2021-2032)
  3. 8.2.1 North America Targeted RNA Sequencing Revenue by Type (2021-2026)
  4. 8.2.2 North America Targeted RNA Sequencing Revenue by Type (2027-2032)
  5. 8.3 North America Targeted RNA Sequencing Revenue Share by Type (2021-2032)
  6. 8.4 North America Targeted RNA Sequencing Revenue by Application (2021-2032)
  7. 8.4.1 North America Targeted RNA Sequencing Revenue by Application (2021-2026)
  8. 8.4.2 North America Targeted RNA Sequencing Revenue by Application (2027-2032)
  9. 8.5 North America Targeted RNA Sequencing Revenue Share by Application (2021-2032)
  10. 8.6 North America Targeted RNA Sequencing Revenue by Country
  11. 8.6.1 North America Targeted RNA Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Targeted RNA Sequencing Revenue by Country (2021-2026)
  13. 8.6.3 North America Targeted RNA Sequencing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Targeted RNA Sequencing Revenue (2021-2032)
  2. 9.2 Europe Targeted RNA Sequencing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Targeted RNA Sequencing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Targeted RNA Sequencing Revenue by Type (2027-2032)
  5. 9.3 Europe Targeted RNA Sequencing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Targeted RNA Sequencing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Targeted RNA Sequencing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Targeted RNA Sequencing Revenue by Application (2027-2032)
  9. 9.5 Europe Targeted RNA Sequencing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Targeted RNA Sequencing Revenue by Country
  11. 9.6.1 Europe Targeted RNA Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Targeted RNA Sequencing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Targeted RNA Sequencing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Targeted RNA Sequencing Revenue (2021-2032)
  2. 10.2 China Targeted RNA Sequencing Revenue by Type (2021-2032)
  3. 10.2.1 China Targeted RNA Sequencing Revenue by Type (2021-2026)
  4. 10.2.2 China Targeted RNA Sequencing Revenue by Type (2027-2032)
  5. 10.3 China Targeted RNA Sequencing Revenue Share by Type (2021-2032)
  6. 10.4 China Targeted RNA Sequencing Revenue by Application (2021-2032)
  7. 10.4.1 China Targeted RNA Sequencing Revenue by Application (2021-2026)
  8. 10.4.2 China Targeted RNA Sequencing Revenue by Application (2027-2032)
  9. 10.5 China Targeted RNA Sequencing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Targeted RNA Sequencing Revenue (2021-2032)
  2. 11.2 Asia Targeted RNA Sequencing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Targeted RNA Sequencing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Targeted RNA Sequencing Revenue by Type (2027-2032)
  5. 11.3 Asia Targeted RNA Sequencing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Targeted RNA Sequencing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Targeted RNA Sequencing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Targeted RNA Sequencing Revenue by Application (2027-2032)
  9. 11.5 Asia Targeted RNA Sequencing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Targeted RNA Sequencing Revenue by Country
  11. 11.6.1 Asia Targeted RNA Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Targeted RNA Sequencing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Targeted RNA Sequencing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Targeted RNA Sequencing Revenue (2021-2032)
  2. 12.2 SAMEA Targeted RNA Sequencing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Targeted RNA Sequencing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Targeted RNA Sequencing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Targeted RNA Sequencing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Targeted RNA Sequencing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Targeted RNA Sequencing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Targeted RNA Sequencing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Targeted RNA Sequencing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Targeted RNA Sequencing Revenue by Country
  11. 12.6.1 SAMEA Targeted RNA Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Targeted RNA Sequencing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Targeted RNA Sequencing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst